We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
FHN icon
First Horizon
FHN
+$107M
3
SGFY
Signify Health, Inc.
SGFY
+$54.9M
4
VMW
VMware, Inc
VMW
+$34.9M
5
ONEM
1Life Healthcare
ONEM
+$29.7M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
ROG icon
Rogers Corp
ROG
+$432M
4
AVLR
Avalara, Inc.
AVLR
+$373M
5
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENPH icon
101
Enphase Energy
ENPH
$5.24B
– –
-14,955
Closed -$4.15M
EPR icon
102
EPR Properties
EPR
$4.7B
– –
-30,989
Closed -$1.11M
EQIX icon
103
Equinix
EQIX
$104B
– –
-2,366
Closed -$1.35M
EQR icon
104
Equity Residential
EQR
$25B
– –
-65,779
Closed -$4.42M
EQT icon
105
EQT Corp
EQT
$32.3B
– –
-43,181
Closed -$1.76M
ESPR
106
DELISTED
Esperion Therapeutics
ESPR
– –
-77,000
Closed -$516K
ESS icon
107
Essex Property Trust
ESS
$18.3B
– –
-31,729
Closed -$7.69M
ESTA icon
108
Establishment Labs
ESTA
$2.33B
– –
-17,926
Closed -$979K
ET icon
109
Energy Transfer Partners
ET
$71.2B
– –
-50,000
Closed -$552K
ETN icon
110
Eaton
ETN
$174B
– –
-95,438
Closed -$12.7M
ETNB
111
DELISTED
89bio
ETNB
– –
-92,034
Closed -$533K
ETR icon
112
Entergy
ETR
$49.7B
– –
-73,086
Closed -$3.68M
EVLV icon
113
Evolv Technologies
EVLV
$1.07B
– –
-1,431,739
Closed -$3.04M
EVLVW
114
DELISTED
Evolv Technologies Warrant
EVLVW
– –
-715,785
Closed -$340K
EVRG icon
115
Evergy
EVRG
$19.1B
– –
-21,698
Closed -$1.29M
EWTX icon
116
Edgewise Therapeutics
EWTX
$4.78B
– –
-110,750
Closed -$1.09M
EXPE icon
117
Expedia Group
EXPE
$36.8B
– –
-6,000
Closed -$562K
EXPE icon
118
PUT
Expedia Group
EXPE
$36.8B
– –
-13,500
Closed -$684K
EXR icon
119
Extra Space Storage
EXR
$31.6B
– –
-71,926
Closed -$12.4M
F icon
120
PUT
Ford
F
$55B
– –
-423,500
Closed -$580K
FAF icon
121
First American
FAF
$7.67B
– –
-89,118
Closed -$4.11M
FANG icon
122
Diamondback Energy
FANG
$53.1B
– –
-5,600
Closed -$675K
FCPT icon
123
Four Corners Property Trust
FCPT
$2.75B
– –
-263,700
Closed -$6.38M
FE icon
124
FirstEnergy
FE
$27.4B
– –
-174,312
Closed -$6.45M
FIS icon
125
Fidelity National Information Services
FIS
$22.1B
– –
-50,000
Closed -$3.78M
3 4
5
6 7

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.